Get to know FDA’s drug development and approval process — ensuring that drugs work and that the benefits outweigh their known risks.
Similar Posts
Spring & Mulberry Issues Voluntary Recall of Mint Leaf Date Sweetened Chocolate Bar Due to Possible Salmonella Contamination
Raleigh, North Carolina (January 12, 2026) — Spring & Mulberry is voluntarily recalling lot #025255 of its Mint Leaf Date Sweetened Chocolate Bar (2.1 oz) due to possible contamination with Salmonella.Primary Care Providers Can Prescribe with Confidence
Information and resources are available to help primary care providers manage OUD with the help of medications for opioid use disorder (MOUD).Biosimilars | Science and Research
Learn about FDA’s latest in biosimilar science and research.Correction Alert: Medline Industries, LP Updates Use Instructions for Medline Kits Containing Flexicare BritePro Solo Fiber Optic Laryngoscope Handles
Medline is updating labels for their medical kits containing the Flexicare BritePro Solo due to the light not illuminating as intended.Other | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been granted for supportive care products and changes to dosing or formulation.Untitled Letters
These letters are supplied by the CDER Freedom of Information Office and only cover Office of Prescription Drug Promotion’s untitled letters. FDA may have redacted or edited some of the letters to remove confidential information.